ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 19.5 | 14.1 | 10.8 |
| Other income | 0.1 | 0.0 | 0.0 |
| Total income | 19.6 | 14.1 | 10.9 |
| Profit before exceptional items & tax | 3.3 | 2.9 | 2.2 |
| Profit before tax | 3.3 | 2.9 | 2.2 |
| Net profit | 2.7 | 2.4 | 1.7 |
| Operating margin | 16.8% | 20.6% | 20.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +58.80% |
|---|---|
| Net profit, quarter on quarter | +12.50% |
| Revenue, year on year | +80.60% |
BSE results filing, BSE: 544694. Figures extracted from the filing.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹344.00
- Market cap
- ₹249.1 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 49.1×Sector 43.8×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Investor Presentation: Key Takeaways
H1 FY27 (Apr–Sep 2026): revenue ₹29.44 Cr (+109.35% YoY), EBITDA ₹6.26 Cr (21.27% margin), PAT ₹4.73 Cr (16.06% margin). Focus on capacity expansion and product diversification.
Accretion Nutraveda Results Update
Accretion Nutraveda released a half-year media release showing revenue up 109.35% to Rs 29.44 crore. EBITDA rose 88.03% and PAT rose 98.66%.
Accretion Nutraveda H1 FY27 Results: Net Profit ₹4.7 Cr, Up 95.8% YoY
Accretion Nutraveda Ltd reported revenue from operations of ₹29.4 Cr (+108.5% YoY) and net profit of ₹4.7 Cr (+95.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.7 Cr · +95.8% YoY
Accretion Nutraveda Other Announcement
Accretion Nutraveda's quarterly shareholding pattern shows promoters holding 73.48%. The routine filing reports no corporate action or event value.
Accretion Nutraveda Board Meeting Date
Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited announced results of its postal ballot. Shareholders approved special resolutions regarding MOA alteration, borrowing limits, and various loan and guarantee authorizations.